免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / A T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery (TDRAIN)

A T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery (TDRAIN)

Study Description
Brief Summary:
Assessing the use of a T drain approach for an anastomotic leak after gastrointestinal surgery. The study's aim is to retrospectively assess the safety and benefits of this approach.

Condition or disease Intervention/treatment
Colorectal Cancer Diverticulitis Procedure: Re-laparotomy

Detailed Description:
Assessing the use of a T drain approach for an anastomotic leak after gastrointestinal surgery. The T drain approach is inserting a latex t tube drain into the leak site of the anastomosed bowel and diverting the fecal matter. The study's aim is to retrospectively assess the safety and benefits of this approach.
Study Design
Layout table for study information
Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Retrospective Study Using a T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery
Actual Study Start Date : January 1, 2014
Actual Primary Completion Date : December 31, 2018
Actual Study Completion Date : December 31, 2018
Arms and Interventions
Group/Cohort Intervention/treatment
T drain
Patients treated with a T drain approach
Procedure: Re-laparotomy
Stoma
Patients treated with a stoma
Procedure: Re-laparotomy
Outcome Measures
Primary Outcome Measures :
  1. Measuring severity of complications with the Dindo Clavien complications scale [ Time Frame: 30 day post operation ]
    By using the Dindo Clavien complications scale assessment of recuperation and complications rate and severity following re-laparotomy and assessing if another surgery was avoided.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients after elective or emergent gastrointestinal surgery with a leak in their GI anastomosis
Criteria

Inclusion Criteria:

  • Patients after elective or emergent gastrointestinal surgery with a leak in their GI anastomosis

Exclusion Criteria:

  • under 18 years of age
  • Pregnancy
Contacts and Locations

Locations
Layout table for location information
Israel
Meir Medical Center
Kfar Saba, Israel
Sponsors and Collaborators
Meir Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Yaron Rudnicki, MD Meir Medical Center Israel
Tracking Information
First Submitted Date May 26, 2019
First Posted Date June 5, 2019
Last Update Posted Date June 5, 2019
Actual Study Start Date January 1, 2014
Actual Primary Completion Date December 31, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 4, 2019)
Measuring severity of complications with the Dindo Clavien complications scale [ Time Frame: 30 day post operation ]
By using the Dindo Clavien complications scale assessment of recuperation and complications rate and severity following re-laparotomy and assessing if another surgery was avoided.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title A T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery
Official Title A Retrospective Study Using a T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery
Brief Summary Assessing the use of a T drain approach for an anastomotic leak after gastrointestinal surgery. The study's aim is to retrospectively assess the safety and benefits of this approach.
Detailed Description Assessing the use of a T drain approach for an anastomotic leak after gastrointestinal surgery. The T drain approach is inserting a latex t tube drain into the leak site of the anastomosed bowel and diverting the fecal matter. The study's aim is to retrospectively assess the safety and benefits of this approach.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients after elective or emergent gastrointestinal surgery with a leak in their GI anastomosis
Condition
  • Colorectal Cancer
  • Diverticulitis
Intervention Procedure: Re-laparotomy
Study Groups/Cohorts
  • T drain
    Patients treated with a T drain approach
    Intervention: Procedure: Re-laparotomy
  • Stoma
    Patients treated with a stoma
    Intervention: Procedure: Re-laparotomy
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: June 4, 2019)
50
Original Actual Enrollment Same as current
Actual Study Completion Date December 31, 2018
Actual Primary Completion Date December 31, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patients after elective or emergent gastrointestinal surgery with a leak in their GI anastomosis

Exclusion Criteria:

  • under 18 years of age
  • Pregnancy
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT03974672
Other Study ID Numbers MMC-0340-16-CTIL
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Plan Description: All none identifying patients information
Responsible Party yaron rudnicki, Meir Medical Center
Study Sponsor Meir Medical Center
Collaborators Not Provided
Investigators
Principal Investigator: Yaron Rudnicki, MD Meir Medical Center Israel
PRS Account Meir Medical Center
Verification Date June 2019

治疗医院